8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
Vistagen Therapeutics, Inc.（CIK: 0001411685）于 2026-10-30 提交 8-K，报告期为 2026-10-26，涉及 Item 2.05（退出或处置活动相关成本）和 Item 8.01（其他事项）。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 17:24:07
Documents
11
Period of Report
2026-10-26
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | 8-K | vtgn-20261026.htm iXBRL | 8-K | 25284 |
| Complete submission text file | 0001628280-26-068627.txt | 140391 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vtgn-20261026.xsd | EX-101.SCH | 1785 |
| 3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vtgn-20261026_lab.xml | EX-101.LAB | 21629 |
| 4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vtgn-20261026_pre.xml | EX-101.PRE | 12510 |
| 15 | EXTRACTED XBRL INSTANCE DOCUMENT | vtgn-20261026_htm.xml | XML | 2729 |
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)
EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 261509121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov